Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
www.pharmacytimes.com News|Articles|October 14, 2025 GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders Author(s) Kennedy Ferruggia, Assistant Editor Listen 0:00 / 4:56 Key Takeaways GLP-1 receptor agonists may treat alcohol and substance use disorders by modulating addiction-related neurobiological pathways, reducing cravings and substance use
However, this product is not intended to diagnose, treat, or cure any disease
While some adolescent bariatric surgeons still perform gastric bypass, the gastric sleeve has become the preferred approach for the vast majority of adolescent patients nationwide
GLP-1 analogs such as ROSE-010 have also shown therapeutic potential
Legal gray areas: Possession may be legal, but sale for human use often isn't
US$ 22.07
US$ 26.03
US$ 24.53
US$ 27.87
US$ 28.92
